Search
Veracyte Inc
VCYTAdd to Watchlist
24.160USD
+0.160+0.67%
Close 11-06 16:00（ET）
1.94BMarket Cap
21.70P/E TTM
Veracyte Inc (VCYT) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Veracyte Inc in the past month.
Buy
6 Strong Buy
5 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
58.545USD+17.07%
VCYT Analyst Recommendation Trends
In the current month, VCYT has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. VCYT average Analyst price target in the last month is 58.545.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
6
6
6
6
6
6
5
5
5
5
5
4
4
5
5
5
1
1
1
1
1
1
2
2
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
12
13
13
12
12
13
13
13
VCYT Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, VCYT EPS is projected to reach 0.447 in FY2026Q4, following reported EPS of 0.391 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.15
0.26
0.41
0.45
0.42
Actual
0.36
0.32
0.39
--
--
Surprise
+145.30%
+22.59%
-4.68%
--
--
FAQs
What is Veracyte Inc's expected revenue for the next quarter?
Veracyte Inc's expected revenue is 157.32M.
What is Veracyte Inc's price target?
Analysts forecast that Veracyte Inc's price target is USD 57.45, with the highest forecast at USD 70.00 and the lowest forecast at USD 40.00.
How have Veracyte IncVCYT's recent earnings per share performed?
The market expectation was USD 0.39, while Veracyte IncVCYT's earnings per share (EPS) for the previous quarter was USD 0.32. EPS for the next quarter is expected at USD 0.45.
What is the analyst rating for Veracyte Inc?
Based on the ratings of Veracyte Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.